Clinical Trial Update: Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects [Phase 3]

View source ↗

Summary

A Phase 3 study assessing the immunogenicity, safety, and efficacy of a high-capacity process etanercept in rheumatoid arthritis has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2017-05-15